MedPath

Octreotide acetate

Octreotide Acetate Injection

Approved
Approval ID

dec280fa-6646-4cfe-916e-5f3485378050

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 10, 2012

Manufacturers
FDA

Wockhardt Limited

DUNS: 650069115

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Octreotide acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55648-632
Application NumberANDA090986
Product Classification
M
Marketing Category
C73584
G
Generic Name
Octreotide acetate
Product Specifications
Route of AdministrationINTRAVENOUS, SUBCUTANEOUS
Effective DateSeptember 13, 2012
FDA Product Classification

INGREDIENTS (6)

OCTREOTIDE ACETATEActive
Quantity: 1000 ug in 1 mL
Code: 75R0U2568I
Classification: ACTIM
ACETIC ACIDInactive
Code: Q40Q9N063P
Classification: IACT
PHENOLInactive
Code: 339NCG44TV
Classification: IACT
SODIUM ACETATEInactive
Code: 4550K0SC9B
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.